Cited by 121Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesNicotinic Acetylcholine Receptors Study

Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis

Open access
Roberts, Emmert, Eden Evins, A., McNeill, Ann, Robson, Debbie·2016·Addiction

Abstract

BACKGROUND AND AIMS: To assess the efficacy and tolerability of adjunctive pharmacotherapy for smoking cessation in adults with serious mental illness (SMI) by means of a systematic review and network meta-analysis. METHOD: We searched Embase, Medline, PsychINFO and the Cochrane Central Register of Controlled Trials from database inception to 1 December 2014 for randomized controlled trials (RCTs) published in English. We included all studies of smokers with SMI (including schizophrenia, schizoaffective disorder, bipolar disorder, delusional disorder and depressive psychoses) who were motivated to quit smoking. Pharmacotherapies included nicotine replacement therapy (NRT), bupropion and varenicline delivered as monotherapy or in combination compared with each other or placebo. The efficacy outcome was self-reported sustained smoking cessation, verified biochemically at the longest reported time-point. The tolerability outcome was number of patients discontinuing the trial due to any adverse event. RESULTS: Seventeen study reports were included, which represented 14 individual RCTs. No trials were found in patients with depressive psychoses, delusional disorder or that compared NRT monotherapy with placebo. A total of 356 and 423 participants were included in the efficacy and tolerability analyses, respectively. From the network meta-analysis, both bupropion and varenicline were more effective than placebo [odds ratio (OR) = 4.51, 95% credible interval (CrI) = 1.45-14.04 and OR = 5.17, 95% CrI = 1.78-15.06, respectively]. Data were insensitive to an assessment of varenicline versus bupropion (OR = 1.15, 95% CrI = 0.24-5.45). There were no significant differences in tolerability. All outcomes were rated by GRADE criteria as very low quality. CONCLUSIONS: The limited evidence available to date suggests that bupropion and varenicline are effective and tolerable for smoking cessation in adults with serious mental illnesses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/add.13236

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It has not yet been fully established whether task-sharing approaches will reduce premature mortality, improve wellbeing, and achieve better social outcomes in low-income and middle-income country settings.

    “However, whether such approaches will be successful in reducing premature mortality, improving wellbeing and achieving better social outcomes in LMIC settings has yet to be fully established.324”
  • Case studies from non-governmental organisations indicate that inefficient health system structures can create barriers to successful task-sharing.

    “Case studies from non-governmental organisations indicate that inefficient health system structures can present barriers to successful task-sharing; indicating a need for more CC services.324”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [21]Kreinin A Novitski D Rabinowitz D Weizman A Grinshpoon A Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients Compr Psychiatry 2012 53 3 269 74 21664608
  2. [60]Shim JC Jung DU Jung SS Seo YS Cho DM Lee JH Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: A randomized double-blind placebo-controlled trial Neuropsychopharmacology 2012 37 3 660 668 22048460 PMC3260973

Cited by

Sorted by citations

Authors
Roberts, E., Eden Evins, A., McNeill, A., & Robson, D.
Affiliations
  • King's College London (GB)
  • William Cox Family Associate Professor of Psychiatry in the Field of Addiction Medicine Harvard Medical School Boston MA USA
Corresponding author
Roberts, Emmert
Venue
Addiction
Publisher
Wiley
Published
2016-01-19
Volume
111
Issue
4
Pages
599-612
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W2179657949
Cited by
119
References
60
Citations by year
2026: 1 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 11 · 2021: 9 · 2020: 12 · 2019: 15 · 2018: 17 · 2017: 22 · 2016: 12 · 2015: 2
FWCI
2.16
Type
journal article
Language
en
Open access
Locations
  • Addiction (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute for Health and Care Research (ACF-2014-17-009)
  • Medical Research Council (MR/K023195/1)
  • Economic and Social Research Council (ES/G007489/1)
  • National Institute on Drug Abuse (K24DA030443)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords
smoking cessation, severe mental illness, pharmacotherapy, nicotine replacement therapy, bupropion, varenicline, schizophrenia, bipolar disorder, schizoaffective disorder, adverse events
MeSH terms
Varenicline, Mental Disorders, Humans, Tobacco Use Disorder, Smoking Cessation, Bupropion, Treatment Outcome, Nicotinic Agonists, Tobacco Use Cessation Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review